3 Clinical psychopharmacology3.3 Pharmacodynamics

3.3.1.3 Receptor binding mechanisms and affinity

1 min read1 figure

Written by Resident Doctor Committee · Published

Affinity and the dissociation constant

  • Affinity is how strongly a drug binds its receptor; efficacy is the signalling response it produces once bound.

  • At equilibrium, association and dissociation rates are equal, and the dissociation constant Kd = koff / kon.

  • Kd has concentration units, and a lower Kd means higher affinity.

  • Clozapine and quetiapine dissociate from D2 receptors faster than haloperidol or risperidone, which may explain their lower extrapyramidal and prolactin effects.

Potency

  • Potency (EC50) is set jointly by a drug's affinity for its receptor and its efficacy once bound.

  • Agonists, partial agonists, neutral antagonists and inverse agonists can have similar affinity yet different effects, because their efficacy differs.

Occupancy

  • Fractional occupancy at equilibrium = [L] / ([L] + Kd), where [L] is the free concentration at the receptor, so half the receptors are occupied when [L] equals Kd.

  • Occupancy rises hyperbolically: going from 50 to 90 per cent occupancy needs a ninefold rise in concentration.

D2 occupancy and antipsychotic effects

Positron emission tomography (PET) estimates occupancy in the living brain from the fall in radiotracer binding after a dose.

Striatal D2 occupancy

Effect

About 65 per cent

Antipsychotic response

About 72 per cent

Hyperprolactinaemia

Above about 80 per cent

Extrapyramidal side effects rise steeply

  • Raising the dose beyond 80 per cent adds harm with little benefit, though clozapine can work at 40 to 60 per cent.

  • Selective serotonin reuptake inhibitors occupy about 80 per cent of serotonin transporters at minimum effective doses.

Follow the curve as it flattens above 80 per cent: striatal D2 occupancy rises hyperbolically with dose, so antipsychotic response at about 65 per cent and hyperprolactinaemia at about 72 per cent come before a steep rise in extrapyramidal side effects, and higher doses add little further occupancy. Drawn for MRCPsychiatrist